Thomas Stax Jakobsen - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Molecular Therapy. Nucleic Acids|February 6, 2026

AAV-mediated multiple gene therapy combining VEGFA-targeting miR-agshRNAs and PEDF for the suppression of choroidal neovascularizationBjørn K Fabian-Jessing, Anne Louise Askou, Thomas Stax Jakobsen, et al.

Molecular Therapy. Methods & Clinical Development|December 22, 2025

Nanobody-based gene therapy targeting complement component C3 reduces choroidal neovascularization in miceEmilie Grarup Jensen, Thomas Stax Jakobsen, Gloriane Schnabolk, et al.

Nucleic Acids Research|September 7, 2023

Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modificationJakob Haldrup, Sofie Andersen, Alexander Rafael LaVilla Labial, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Molecular Therapy. Nucleic Acids|February 6, 2026

AAV-mediated multiple gene therapy combining VEGFA-targeting miR-agshRNAs and PEDF for the suppression of choroidal neovascularizationBjørn K Fabian-Jessing, Anne Louise Askou, Thomas Stax Jakobsen, et al.

Molecular Therapy. Methods & Clinical Development|December 22, 2025

Nanobody-based gene therapy targeting complement component C3 reduces choroidal neovascularization in miceEmilie Grarup Jensen, Thomas Stax Jakobsen, Gloriane Schnabolk, et al.

Nucleic Acids Research|September 7, 2023

Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modificationJakob Haldrup, Sofie Andersen, Alexander Rafael LaVilla Labial, et al.

Pageof 2